Industry Overview

UK oncology information system market was valued at $222.2 million in 2025 and is projected to reach $503.2 million by 2035, registering a CAGR of 8.6% during the forecast period. Oncology information systems are sophisticated healthcare IT solutions designed to manage cancer patient data, streamline clinical workflows, and support comprehensive treatment planning across oncology departments. These systems integrate electronic health records, imaging data, radiotherapy planning tools, and clinical decision support systems, enabling healthcare providers to deliver more coordinated, efficient, and personalized cancer care. The market growth is primarily driven by the rising prevalence of cancer, increasing demand for digital transformation in healthcare, and the growing adoption of precision medicine approaches across the UK.

Healthcare providers are increasingly investing in advanced and integrated IT infrastructure to improve patient outcomes, minimize treatment errors, and enhance operational efficiency. The shift toward value-based care models, along with the growing need for real-time data analytics and interoperability, is further accelerating the adoption of oncology information systems. In March 2026, Siemens Healthineers introduced its new Artis angiography family featuring AI-powered imaging capabilities to improve precision in interventional procedures, including cancer therapies. The system supports personalized, image-guided oncology treatments while optimizing clinical workflows. Such technological advancements are strengthening the broader digital oncology ecosystem and indirectly contributing to the expansion of the oncology information system market across the UK.

Market Dynamics

Digital Transformation Accelerates UK Oncology Software Adoption

Software segment leads the UK oncology information system market due to growing adoption of digital platforms for patient data management and workflow optimization. These systems enable seamless integration of imaging, radiotherapy, and electronic health records across care settings. In February 2026, the UK Department of Health and Social Care and NHS England launched the National Cancer Plan for England to advance AI-driven diagnostics and integrated data systems. The initiative supports improved treatment planning across medical, radiation, and surgical oncology. As a result, oncology software adoption is expected to rise across NHS hospitals, cancer centers, and research institutions, enhancing efficiency and patient outcomes.

Radiation Oncology Driving Growth in Oncology Information Systems

Radiation oncology continues to lead the application segment due to the growing adoption of advanced radiotherapy techniques in cancer care. Oncology information systems play a vital role in enabling precise treatment planning, accurate dose calculation, and streamlined clinical workflows. In May 2024, Elekta AB enhanced its oncology software capabilities by acquiring the Pinnacle treatment planning patent portfolio from Philips Healthcare. This strategic move strengthens treatment planning efficiency and supports advanced workflow optimization within Elekta’s software ecosystem. As a result, innovation in radiation oncology software continues to accelerate adoption across hospitals and cancer treatment centers.

Market Segmentation

• Based on product type, the market is segmented into software and services.
• Based on application, the market is segmented into medical oncology, radiation oncology, and surgical oncology.
• Based on end-user, the market is segmented into hospitals, cancer treatment centers, and research & academic institutes.

Hospitals Lead Adoption of AI-Driven Oncology Systems

Hospitals continue to dominate the end-user segment due to their advanced infrastructure, high patient volumes, and strong adoption of integrated IT systems. They extensively rely on oncology information systems to manage complex cancer treatment workflows and improve care coordination. In March 2026, GE HealthCare highlighted its AI-enabled imaging and cloud-based innovations at the ECR 2026 to enhance precision care. These solutions, including advanced PET/CT and SPECT/CT technologies, support accurate diagnosis, staging, and treatment planning. Such advancements are strengthening hospital-based oncology systems by improving data integration, workflow efficiency, and clinical decision-making.

Market Players Outlook

The major companies operating in the UK oncology information system market include McKesson Corporation, Siemens Healthineers, GE HealthCare, Philips Healthcare, and Oracle Health, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisitions to expand their businesses and develop innovative products, maintaining their market positioning.

Recent Development

• In October 2025, Careology partnered with Boots and Guy's and St Thomas’ NHS Foundation Trust to launch a tech-enabled cancer care navigation service in the UK. Through the Careology app, cancer patients experiencing low-risk chemotherapy side effects can access remote support, advice, and prescription services from Boots Macmillan Information Pharmacists.

• In May 2025, NTT DATA partnered with The Royal Marsden NHS Foundation Trust and CARPL.ai to launch an AI-powered radiology analysis service aimed at advancing cancer detection and treatment research. Supported by a three-year grant from the UK’s National Institute for Health and Care Research (NIHR), the platform helped researchers develop and evaluate AI algorithms for cancers including lung, breast, brain, prostate, and sarcoma

The Report Covers

• Market value data analysis of 2025 and forecast to 2035.
• Annualized market revenues ($ million) for each market segment.
• Key companies operating in the UK oncology information system market
• Based on the availability of data, information related to new protections and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.